JENNIFER LEIGH MCQUADE to Infliximab
This is a "connection" page, showing publications JENNIFER LEIGH MCQUADE has written about Infliximab.
Connection Strength
0.246
-
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study. J Immunother Cancer. 2021 11; 9(11).
Score: 0.190
-
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series. J Immunother Cancer. 2024 01 31; 12(1).
Score: 0.056